Advertisement

Organisation › Details
Bayern Kapital Risikokapitalbeteiligungs GmbH
Bayern Kapital is the venture capital company of the Free State of Bavaria and, with 700 million euros under management, investments of up to 25 million euros per company, over 110 active portfolio companies and 30 years of experience in the VC business, is one of the most active, financially strongest and most experienced investors in the DACH region. Bayern Kapital invests in a consortium with private investors in Bavarian high-tech and deep-tech start-ups and scale-ups with innovative business models from all sectors, from the seed and scale-up phase through to exit. Since it was founded in 1995, Bayern Kapital has invested over 500 million euros of its own equity capital in more than 320 start-ups and scale-ups from sectors such as life sciences, software & IT, materials & new materials, nanotechnology and environmental technology. This has created over 10,000 permanent jobs in sustainable companies in Bavaria. Examples of numerous pioneering success stories that Bayern Kapital has supported from an early stage include Casavi, Catalym, commercetools, egym, EOS, Fazua, Immunic, Isar Aerospace, IQM, Parcellab, Proglove, Qbilon, Riskmethods, SimScale, Sirion, tado, Tubulis and many more. *
![]() |
Start | 1995-12-01 established |
![]() |
Industry | venture capital |
![]() |
Person | Ried, Georg (Bavaria (govt) 201607 Managing Director of Bayern Kapital) |
Street | 135 a Ländgasse | |
City | 84028 Landshut | |
Tel | 0871-92325-0 | |
Address record changed: 2024-05-08 | ||
Basic data | Employees | n. a. |
Currency | EUR | |
Annual sales | 700,000,000 (capital under management (2025) 2025-03-12) | |
* Document for »About Section«: Vantis. (3/12/25). "Press Release: Munich-based HealthTech Startup Vantis Secures 10 Million Euros in Series A Financing Round Led by Angelini Ventures". Munich. | ||
Record changed: 2025-07-06 |
Advertisement

More documents for Bavaria (govt region)
- [1] IZB Martinsried. (3/8/24). "Press Release: Christian Gnam Succeeds Dr. Peter Zobel as New Managing Director of the Biotechnology Innovation and Start-up Center (IZB)". Martinsried....
- [2] Max Planck Society. (4/29/21). "Press Release: Top Address for Life Science Research. Bavaria Invests up to 500 Million Euros in the Competitive Development of the Martinsried Max Planck Campus into an Outstanding International Research Hub"....
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com
Advertisement

» top